---
title: "Dyne Therapeutics falls 6% during regular trading on earnings concerns"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293483637.md"
description: "Dyne Therapeutics (DYN) fell 6% to $22.30 during regular trading as earnings-related pressure continued."
datetime: "2026-07-22T13:51:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293483637.md)
  - [en](https://longbridge.com/en/news/293483637.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293483637.md)
generator: "portal-rs"
---

# Dyne Therapeutics falls 6% during regular trading on earnings concerns

Dyne Therapeutics(DYN.US) 盘中跌**6.42%**，现报**22.30**美元。

该股 5 分钟内急跌超 5%。消息面上，Dyne Therapeutics 盘前已因业绩相关因素承压，盘中继续急跌。

### Related Stocks

- [DYN.US](https://longbridge.com/en/quote/DYN.US.md)

## Related News & Research

- [Dyne Therapeutics Stock Tumbles After Hours: Here's Why](https://longbridge.com/en/news/293429148.md)
- [Aegis Wealth Management LLC Invests $3.33 Million in Dyne Therapeutics, Inc. $DYN](https://longbridge.com/en/news/296188072.md)
- [Dyne Therapeutics director Jason P. Rhodes disposes of common shares worth $67.45 million](https://longbridge.com/en/news/296148351.md)
- [Dyne Therapeutics, Inc. $DYN Shares Purchased by Perceptive Advisors LLC](https://longbridge.com/en/news/294603520.md)
- [Dyne Therapeutics Upsized Equity Offering Strengthens Cash Runway](https://longbridge.com/en/news/293529976.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**